HCA

HCA Healthcare, Inc. - Q1 2005 10-Q Summary

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for HCA Inc. for the period ended March 31, 2005. HCA is a holding company whose affiliates own and operate hospitals and related health care entities. As of the reporting date, the company operated 183 hospitals and 84 freestanding surgery centers across 23 U.S. states, England, and Switzerland. The company operates in a single line of business: operating hospitals and related health care entities.

Key Financial Metrics

Note: Long-term debt decreased from the prior quarter due to repayments. Q1 2004 debt figures are not directly comparable on a balance sheet basis as the filing compares Q1 2005 to Q1 2004 income statements but Q1 2005 to Dec 2004 balance sheets.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 4.1% year-over-year, driven by a 1.8% increase in equivalent admissions and a 2.3% increase in revenue per equivalent admission.
• Profitability: Net income rose 20% to $414 million. Diluted earnings per share increased 37.7% to $0.95, significantly aided by a reduction in the share count (435.7 million diluted shares in 2005 vs. 497.6 million in 2004) following a tender offer in late 2004.
• Uninsured Discount Policy: Effective January 1, 2005, HCA implemented a revised policy providing discounts to uninsured patients. This resulted in $109 million in recorded discounts during the quarter, reducing reported revenues and the provision for doubtful accounts.
• Provision for Doubtful Accounts: The provision decreased to 9.3% of revenues (from 11.7% in Q1 2004). Adjusted for the new discount policy, the provision was 10.9% of revenues, indicating a moderation in the deterioration of collectability for uninsured accounts.
• Interest Expense: Increased to $164 million from $135 million in the prior year, primarily due to higher average debt balances ($10.2 billion vs. $8.8 billion) associated with the 2004 tender offer financing.

Guidance, Outlook, and Risks

• Capital Expenditures: Annual planned capital expenditures for 2005 and 2006 are expected to approximate $1.6 billion and $1.8 billion, respectively. Projects under construction have estimated additional costs of $2.2 billion over the next five years.
• Divestitures: HCA announced an intention to divest ten acute care hospitals located in six states.
• Systems Implementation: The company is implementing new payroll and human resources information systems with total estimated expenditures of $332 million. Management expects completion through 2006 but notes risks regarding delays and cost overruns.
• Tax Disputes: HCA is contesting IRS examinations regarding tax years 1990–2002. The IRS has claimed an additional $585 million in taxes and interest. Management believes provisions are adequate and disputes will not have a material adverse effect.
• Regulatory Risks: The company operates under an eight-year Corporate Integrity Agreement (CIA) with the Department of Health and Human Services. Violations could result in fines or exclusion from Medicare/Medicaid programs.
• Market Risk: Approximately $2.13 billion of long-term debt is subject to variable interest rates. A hypothetical 1% increase in interest rates would reduce future pretax earnings by approximately $21 million annually.

Investor Verification Checklist

• Verify the impact of the new uninsured discount policy on future revenue recognition and the provision for doubtful accounts.
• Monitor the progress and cost of the $332 million payroll and HR systems implementation project.
• Track the status of the planned divestiture of ten hospitals and potential proceeds.
• Review updates on the ongoing IRS tax disputes and the $585 million claimed deficiency.
• Assess the company's ability to maintain compliance with the Corporate Integrity Agreement (CIA).
• Confirm the sustainability of the reduced share count and its effect on future EPS growth.